Atossa Therapeutics
ATOS
#9237
Rank
ยฃ77.5 M
Marketcap
ยฃ0.60
Share price
5.24%
Change (1 day)
-36.20%
Change (1 year)

Earnings for Atossa Therapeutics (ATOS)

Earnings in 2025 (TTM): -ยฃ21.8 Million

According to Atossa Therapeutics's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -ยฃ19.15 Million, an increase over its 2023 earnings that were of -ยฃ22.6 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Atossa Therapeutics from 2011 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -ยฃ21.8 Million13.85%
2024 -ยฃ19.15 Million-15.25%
2023 -ยฃ22.6 Million11.62%
2022 -ยฃ20.24 Million30.84%
2021 -ยฃ15.47 Million15.58%
2020 -ยฃ13.39 Million3.41%
2019 -ยฃ12.95 Million51.16%
2018 -ยฃ8.57 Million40.41%
2017 -ยฃ6.1 Million27.54%
2016 -ยฃ4.79 Million-47.49%
2015 -ยฃ9.11 Million-17.25%
2014 -ยฃ11.01 Million35.91%
2013 -ยฃ8.1 Million112.3%
2012 -ยฃ3.82 Million46.53%
2011 -ยฃ2.61 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
ยฃ24.31 B-112,907.30%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
ยฃ1.00 B-4,742.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
ยฃ0.96 B-4,581.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
-ยฃ5.89 Million-72.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Translate Bio
TBIO.defunct
ยฃ31.28 M-245.14%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
-ยฃ81.98 Million 280.29%๐Ÿ‡บ๐Ÿ‡ธ USA